Gilead Remdesivir Licenses Half Measures Are Not Nearly Good Enough Health Gap Global Access Project
Gilead Withdraws Request For Special Orphan Status On Experimental Coronavirus Treatment The New York Times
Health Groups Ask India To Rescind Gilead S Patents For Covid 19 Drug Remdesivir
Gilead Backs Away From Antiviral Monopoly After Criticism
Gilead Criticised Over Orphan Status For Potential Virus Treatment Financial Times